EcoDrugPlus

Ensembl ID : ENSDNOG00000024694
Gene Symbol: -
1 Cross references
238 Possible Orthologues:

Ensembl ID : ENSDNOG00000047795
Gene Symbol: -
1 Cross references
237 Possible Orthologues:

Ensembl ID : ENSDNOG00000024026
Gene Symbol: -
1 Cross references
208 Possible Orthologues:

Ensembl ID : ENSDNOG00000025954
Gene Symbol: -
1 Cross references
274 Possible Orthologues:

Ensembl ID : ENSDNOG00000047508
Gene Symbol: -
1 Cross references
103 Possible Orthologues:

Ensembl ID : ENSDNOG00000015253
Gene Symbol: -
1 Cross references
249 Possible Orthologues:

Ensembl ID : ENSDNOG00000014245
Gene Symbol: -
1 Cross references
237 Possible Orthologues:

Ensembl ID : ENSDNOG00000047684
Gene Symbol: -
1 Cross references
160 Possible Orthologues:

Ensembl ID : ENSDNOG00000012581
Gene Symbol: -
1 Cross references
292 Possible Orthologues:

Ensembl ID : ENSDNOG00000011827
Gene Symbol: -
1 Cross references
252 Possible Orthologues:

Ensembl ID : ENSDNOG00000010589
Gene Symbol: -
1 Cross references
219 Possible Orthologues:

Ensembl ID : ENSDNOG00000009183
Gene Symbol: -
1 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).